Researchers find new role for cannabinoids in vision
McGill Newsroom
Chemicals found to improve low-light vision of tadpoles by sensitizing retinal cells
A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
Simulated patient study sheds new light on antibiotic use in India
McGill Newsroom
As a result of the overuse or misuse of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world’s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.
Novel therapy holds promise of remission in relapsed patients with diffuse large B-cell lymphoma
Gaming camera could aid MS treatment
McGill Newsroom
3D depth-sensing camera shown to measure walking difficulties
A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.
Depression screening in children and adolescents
McGill Newsroom
Researchers find tools inaccurate and advise against routine screening in this age group
Maintaining a healthy heart through bile acids
McGill Newsroom
Canadian discovery may soon lead to the prevention of cardiac fibrosis
Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis—a condition leading to heart failure for which there is currently no treatment.
A molecular on/off switch for antibiotic resistance
McGill Newsroom
Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections.
Now, researchers at McGill University have discovered a possible target for fighting back against resistant bacteria.
Goodman Cancer Research Gala raises $2.1 million
McGill Newsroom
Pioneering research at McGill’s Goodman Cancer Research Centre gets boost
Are EEG neurofeedback benefits due to placebo effects?
Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.
McGill installs inaugural Chair in Pharmacoepidemiology
McGill Newsroom
McGill alumnus tagged to boost capacity and discovery in growing field
Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.
Antidepressants: rise in off-label prescriptions
McGill Newsroom
Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.
Newborn screening for cystic fibrosis
McGill University Health Centre
New study reinforces importance of implementing screening in Quebec
Less body fat for toddlers taking vitamin D
By Fergus Grieve, McGill Newsroom
Supplement given during first year of life critical for muscle-mass development
A healthy intake of vitamin D in the first year of life appears to set children up to have more muscle mass and less body fat as toddlers, according to a new study published in the journal Pediatric Obesity.
A ‘tropical’ parasitic disease emerges in the Arctic
By Julie Robert, McGill University Health Centre
Canadian researchers describe the first outbreak of Cryptosporidium parasite in Nunavik